NASDAQ:STAA - STAAR Surgical Stock Price, Price Target & More

$16.75 +1.25 (+8.06 %)
(As of 04/22/2018 12:35 PM ET)
Previous Close$16.75
Today's Range$15.40 - $16.80
52-Week Range$8.95 - $17.60
Volume183,531 shs
Average Volume103,590 shs
Market Capitalization$696.67 million
P/E Ratio1,675.00
Dividend YieldN/A
Beta1.26

About STAAR Surgical (NASDAQ:STAA)

STAAR Surgical logoSTAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The company provides Visian implantable collamer lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers minimally invasive intraocular lenses (IOLs), including foldable IOLs for use in minimally invasive cataract surgical procedures; aspheric IOLs that produce a clearer image than traditional spherical lenses; and nanoFLEX IOL, a single piece collamer aspheric optic, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision centers, surgical centers, hospitals, government facilities, and distributors primarily under the STAAR, EVO Visian ICL, Evolution in Visual Freedom, Visian, Collamer, CentraFLOW, AquaPORT, nanoFLEX, nanoPOINT, and Afinity trademarks. The company sells products directly through its sales representatives in the United States, Japan, Spain, Germany, Canada, the United Kingdom, and Singapore, as well as through independent distributors in approximately 75 countries. STAAR Surgical Company was founded in 1982 and is headquartered in Monrovia, California.

Receive STAA News and Ratings via Email

Sign-up to receive the latest news and ratings for STAA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Ophthalmic goods
Sub-IndustryHealth Care Supplies
SectorMedical
SymbolNASDAQ:STAA
CUSIP85231230
Phone626-303-7902

Debt

Debt-to-Equity Ratio0.01%
Current Ratio2.82%
Quick Ratio2.13%

Price-To-Earnings

Trailing P/E Ratio1,675.00
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$90.61 million
Price / Sales7.69
Cash Flow$0.0914 per share
Price / Cash183.23
Book Value$1.04 per share
Price / Book16.11

Profitability

EPS (Most Recent Fiscal Year)$0.01
Net Income$-2,130,000.00
Net Margins-2.36%
Return on Equity-2.28%
Return on Assets-1.34%

Miscellaneous

Employees353
Outstanding Shares41,590,000

How to Become a New Pot Stock Millionaire

STAAR Surgical (NASDAQ:STAA) Frequently Asked Questions

What is STAAR Surgical's stock symbol?

STAAR Surgical trades on the NASDAQ under the ticker symbol "STAA."

How were STAAR Surgical's earnings last quarter?

STAAR Surgical (NASDAQ:STAA) issued its quarterly earnings data on Wednesday, February, 28th. The medical instruments supplier reported $0.02 earnings per share for the quarter, missing analysts' consensus estimates of $0.03 by $0.01. The medical instruments supplier had revenue of $24.85 million for the quarter. STAAR Surgical had a negative net margin of 2.36% and a negative return on equity of 2.28%. View STAAR Surgical's Earnings History.

When is STAAR Surgical's next earnings date?

STAAR Surgical is scheduled to release their next quarterly earnings announcement on Wednesday, May, 2nd 2018. View Earnings Estimates for STAAR Surgical.

What price target have analysts set for STAA?

2 brokers have issued 12-month target prices for STAAR Surgical's stock. Their predictions range from $20.00 to $21.00. On average, they anticipate STAAR Surgical's share price to reach $20.50 in the next twelve months. View Analyst Ratings for STAAR Surgical.

Who are some of STAAR Surgical's key competitors?

Who are STAAR Surgical's key executives?

STAAR Surgical's management team includes the folowing people:
  • Ms. Caren L. Mason, Chief Exec. Officer, Pres and Director (Age 64)
  • Dr. Keith Holliday, Chief Technology Officer (Age 55)
  • Mr. Samuel J. Gesten J.D., Chief Legal Officer & Corp. Sec. (Age 56)
  • Mr. Hans-Martin Blickensdoerfer, Sr. VP of Commercial Operations - Europe & China (Age 53)
  • Ms. Deborah Andrews, Chief Financial Officer (Age 61)

Has STAAR Surgical been receiving favorable news coverage?

Media coverage about STAA stock has been trending somewhat positive on Sunday, according to Accern. The research firm identifies positive and negative press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. STAAR Surgical earned a news sentiment score of 0.22 on Accern's scale. They also gave press coverage about the medical instruments supplier an impact score of 47.86 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

How do I buy shares of STAAR Surgical?

Shares of STAA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is STAAR Surgical's stock price today?

One share of STAA stock can currently be purchased for approximately $16.75.

How big of a company is STAAR Surgical?

STAAR Surgical has a market capitalization of $696.67 million and generates $90.61 million in revenue each year. The medical instruments supplier earns $-2,130,000.00 in net income (profit) each year or $0.01 on an earnings per share basis. STAAR Surgical employs 353 workers across the globe.

How can I contact STAAR Surgical?

STAAR Surgical's mailing address is 1911 WALKER AVENUE, MONROVIA CA, 91016. The medical instruments supplier can be reached via phone at 626-303-7902 or via email at [email protected]


MarketBeat Community Rating for STAAR Surgical (STAA)

Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  121 (Vote Outperform)
Underperform Votes:  213 (Vote Underperform)
Total Votes:  334
MarketBeat's community ratings are surveys of what our community members think about STAAR Surgical and other stocks. Vote "Outperform" if you believe STAA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe STAA will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

STAAR Surgical (NASDAQ:STAA) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
2 Wall Street analysts have issued ratings and price targets for STAAR Surgical in the last 12 months. Their average twelve-month price target is $20.50, suggesting that the stock has a possible upside of 22.39%. The high price target for STAA is $21.00 and the low price target for STAA is $20.00. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $20.50$20.50$20.50$15.00
Price Target Upside: 22.39% upside25.77% upside25.77% upside20.48% upside

STAAR Surgical (NASDAQ:STAA) Consensus Price Target History

Price Target History for STAAR Surgical (NASDAQ:STAA)

STAAR Surgical (NASDAQ:STAA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/20/2017BenchmarkReiterated RatingBuy -> Buy$21.00N/AView Rating Details
11/17/2017Canaccord GenuityBoost Price TargetBuy$17.50 -> $20.00N/AView Rating Details
8/4/2016William BlairReiterated RatingMarket PerformN/AView Rating Details
5/12/2016StephensDowngradeOverweight -> Equal WeightN/AView Rating Details
(Data available from 4/22/2016 forward)

Earnings

STAAR Surgical (NASDAQ:STAA) Earnings History and Estimates Chart

Earnings by Quarter for STAAR Surgical (NASDAQ:STAA)

STAAR Surgical (NASDAQ:STAA) Earnings Estimates

Current Year EPS Consensus Estimate: $0.03 EPS

STAAR Surgical (NASDAQ STAA) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/2/2018($0.01)N/AView Earnings Details
2/28/2018Q4 2017$0.03$0.02$24.85 millionViewListenView Earnings Details
11/8/2017Q3 2017$0.02$0.02$23.47 millionViewN/AView Earnings Details
8/2/2017Q2 2017($0.0470)($0.01)$22.15 million$21.90 millionViewListenView Earnings Details
5/3/2017Q1 2017($0.0530)($0.05)$20.35 millionViewListenView Earnings Details
3/2/2017Q4 2016($0.02)$0.02$22.25 million$22.10 millionViewListenView Earnings Details
11/3/2016Q316($0.04)($0.02)$20.70 million$20.05 millionViewListenView Earnings Details
8/3/2016Q216($0.05)($0.05)$19.88 million$21.00 millionViewListenView Earnings Details
5/11/2016Q116($0.17)($0.01)$19.60 million$19.30 millionViewListenView Earnings Details
3/2/2016Q415($0.02)$0.01$19.11 million$20.90 millionViewListenView Earnings Details
10/28/2015Q315($0.04)($0.04)$17.87 million$18.80 millionViewListenView Earnings Details
7/29/2015Q2 2015($0.02)$18.20 million$18.66 millionViewN/AView Earnings Details
4/29/2015Q115($0.04)$0.03$17.85 million$18.90 millionViewListenView Earnings Details
2/25/2015Q414($0.05)($0.03)$16.60 million$16.60 millionViewListenView Earnings Details
10/30/2014Q314$0.02($0.04)$19.53 million$18.20 millionViewListenView Earnings Details
7/30/2014Q214$0.03$0.01$19.80 million$20.05 millionViewListenView Earnings Details
4/28/2014Q114$0.01$0.04$19.44 million$20.20 millionViewListenView Earnings Details
2/26/2014Q413$0.02$0.02$18.98 million$18.90 millionViewListenView Earnings Details
10/30/2013Q313$0.02$0.04$17.35 million$17.10 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.04$0.05$17.40 million$18.20 millionViewListenView Earnings Details
5/1/2013Q1 2013$0.04$0.08$17.27 million$18.00 millionViewListenView Earnings Details
2/27/2013Q4 2012$0.03$0.01$17.55 million$16.50 millionViewListenView Earnings Details
10/31/2012Q312$0.01$0.04$16.78 million$15.90 millionViewN/AView Earnings Details
8/1/2012$0.03$0.03ViewN/AView Earnings Details
5/2/2012$0.03$0.04ViewN/AView Earnings Details
3/6/2012Q4 2011$0.02$0.02ViewN/AView Earnings Details
10/24/2011Q3 2011$0.02$0.01ViewN/AView Earnings Details
8/2/2011Q2 2011$0.01$0.02ViewN/AView Earnings Details
5/3/2011Q1 2011$0.01ViewN/AView Earnings Details
3/1/2011Q4 2010$0.01($0.02)ViewN/AView Earnings Details
11/2/2010Q3 2010$0.01($0.03)ViewN/AView Earnings Details
8/3/2010Q2 2010($0.02)ViewN/AView Earnings Details
5/4/2010Q1 2010($0.01)($0.02)ViewN/AView Earnings Details
3/2/2010Q4 2009($0.03)($0.06)ViewN/AView Earnings Details
11/2/2009Q3 2009($0.03)($0.05)ViewN/AView Earnings Details
8/3/2009Q2 2009($0.01)($0.04)ViewN/AView Earnings Details
5/5/2009Q1 2009($0.05)$0.02ViewN/AView Earnings Details
3/16/2009Q4 2008($0.04)($0.12)ViewN/AView Earnings Details
10/28/2008Q3 2008($0.07)($0.08)ViewN/AView Earnings Details
7/30/2008Q2 2008($0.10)($0.09)ViewN/AView Earnings Details
5/6/2008Q1 2008($0.12)($0.30)ViewN/AView Earnings Details
3/6/2008Q4 2007($0.10)($0.15)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

STAAR Surgical (NASDAQ:STAA) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

STAAR Surgical (NASDAQ STAA) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 5.60%
Institutional Ownership Percentage: 78.95%
Insider Trading History for STAAR Surgical (NASDAQ:STAA)
Institutional Ownership by Quarter for STAAR Surgical (NASDAQ:STAA)

STAAR Surgical (NASDAQ STAA) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/22/2018Deborah J AndrewsCFOSell333$16.05$5,344.6515,667View SEC Filing  
3/22/2018Keith HollidayCTOSell2,188$16.03$35,073.6443,781View SEC Filing  
3/22/2018Samuel J GestenInsiderSell2,833$16.05$45,469.6538,316View SEC Filing  
3/20/2018Keith HollidayInsiderSell1,458$16.05$23,400.9045,969View SEC Filing  
3/19/2018Caren L MasonCEOSell6,667$16.09$107,272.0351,513View SEC Filing  
11/21/2017Keith HollidayVPSell6,000$16.65$99,900.0045,969View SEC Filing  
12/9/2016Hans-Martin BlickensdoerferVPSell25,000$11.14$278,500.00137,380View SEC Filing  
6/29/2016Broadwood Partners LpMajor ShareholderBuy14,144$5.24$74,114.56View SEC Filing  
5/25/2016Broadwood Partners LpMajor ShareholderBuy77,842$5.16$401,664.72View SEC Filing  
5/24/2016Broadwood Partners LpMajor ShareholderBuy70,000$5.16$361,200.00View SEC Filing  
5/23/2016Broadwood Partners LpMajor ShareholderBuy3,138$5.24$16,443.12View SEC Filing  
5/20/2016Richard A MeierDirectorSell25,000$5.35$133,750.0027,149View SEC Filing  
5/17/2016Broadwood Partners LpMajor ShareholderBuy9,313$5.23$48,706.99View SEC Filing  
5/16/2016Broadwood Partners LpMajor ShareholderBuy336,210$5.49$1,845,792.90View SEC Filing  
2/9/2016Broadwood Partners LpMajor ShareholderBuy91,770$6.25$573,562.50View SEC Filing  
2/3/2016Broadwood Partners LpMajor ShareholderBuy121,599$6.40$778,233.60View SEC Filing  
2/1/2016Broadwood Partners LpMajor ShareholderBuy65,983$6.48$427,569.84View SEC Filing  
1/27/2016Broadwood Partners LpMajor ShareholderBuy239,013$6.63$1,584,656.19View SEC Filing  
1/26/2016Broadwood Partners LpMajor ShareholderBuy112,900$6.60$745,140.00View SEC Filing  
1/25/2016Broadwood Partners LpMajor ShareholderBuy81,752$6.74$551,008.48View SEC Filing  
1/20/2016Broadwood Partners LpMajor ShareholderBuy72,858$6.75$491,791.50View SEC Filing  
1/15/2016Broadwood Partners LpMajor ShareholderBuy135,725$6.73$913,429.25View SEC Filing  
1/11/2016Broadwood Partners LpMajor ShareholderBuy86,586$6.83$591,382.38View SEC Filing  
1/7/2016Broadwood Partners LpMajor ShareholderBuy267,047$6.95$1,855,976.65View SEC Filing  
1/4/2016Broadwood Partners LpMajor ShareholderBuy165,461$7.11$1,176,427.71View SEC Filing  
9/29/2015Broadwood Partners LpMajor ShareholderBuy311,099$7.08$2,202,580.92View SEC Filing  
8/25/2015Broadwood Partners LpMajor ShareholderBuy188,881$7.17$1,354,276.77View SEC Filing  
8/24/2015Caren L MasonCEOBuy10,000$7.34$73,400.0014,500View SEC Filing  
4/6/2015Samuel J GestenVPSell3,223$7.14$23,012.22View SEC Filing  
3/3/2015Robin HughesVPSell23,253$15.82$367,862.46View SEC Filing  
11/19/2014Broadwood Partners LpMajor ShareholderBuy189,646$8.64$1,638,541.44View SEC Filing  
11/18/2014Broadwood Partners LpMajor ShareholderBuy39,400$8.67$341,598.00View SEC Filing  
11/17/2014Broadwood Partners LpMajor ShareholderBuy118,200$8.63$1,020,066.00View SEC Filing  
11/10/2014Broadwood Partners LpMajor ShareholderBuy500$8.79$4,395.00View SEC Filing  
11/7/2014Broadwood Partners LpMajor ShareholderBuy80,000$8.92$713,600.00View SEC Filing  
11/4/2014Broadwood Partners LpMajor ShareholderBuy260,341$9.20$2,395,137.20View SEC Filing  
5/15/2014John MooreDirectorSell2,800$14.87$41,636.0076,000View SEC Filing  
3/19/2014James FranceseVPSell16,666$17.22$286,988.5221,960View SEC Filing  
3/17/2014Robin HughesVPSell5,672$16.61$94,211.9256,818View SEC Filing  
9/4/2013Deborah AndrewsCFOSell50,000$12.88$644,000.0036,400View SEC Filing  
8/20/2013Deborah AndrewsCFOSell33,515$11.65$390,449.7536,400View SEC Filing  
8/12/2013Deborah AndrewsCFOSell9,079$11.62$105,497.9822,621View SEC Filing  
8/7/2013Deborah AndrewsCFOSell11,721$11.79$138,190.5924,639View SEC Filing  
5/9/2013Deborah J AndrewsCFOSell5,000$8.96$44,800.00View SEC Filing  
12/11/2012John C MooreDirectorBuy5,000$5.46$27,300.00View SEC Filing  
11/15/2012Broadwood Partners LpMajor ShareholderBuy2,618$5.00$13,090.00View SEC Filing  
11/15/2012Mark B LoganDirectorBuy3,600$5.22$18,792.00View SEC Filing  
11/14/2012Barry G CaldwellCEOBuy5,000$5.04$25,200.00View SEC Filing  
11/2/2012Broadwood Partners LpMajor ShareholderBuy22,572$5.00$112,860.00View SEC Filing  
8/9/2012Barry G CaldwellCEOBuy5,000$6.57$32,850.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

STAAR Surgical (NASDAQ STAA) News Headlines

Source:
DateHeadline
Matthew Haverland Slated To Helm Staar Surgical CompanyMatthew Haverland Slated To Helm Staar Surgical Company
www.prnewswire.com - April 20 at 10:57 AM
STAAR Surgical (STAA) Rating Reiterated by Canaccord GenuitySTAAR Surgical (STAA) Rating Reiterated by Canaccord Genuity
www.americanbankingnews.com - April 19 at 6:54 PM
STAAR Surgical to Report First Quarter Results on May 2, 2018STAAR Surgical to Report First Quarter Results on May 2, 2018
finance.yahoo.com - April 18 at 10:39 AM
Zacks: STAAR Surgical (STAA) Receives Consensus Rating of "Buy" from AnalystsZacks: STAAR Surgical (STAA) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - April 17 at 11:08 PM
STAAR Surgical (STAA) Cut to Sell at BidaskClubSTAAR Surgical (STAA) Cut to Sell at BidaskClub
www.americanbankingnews.com - April 17 at 9:57 AM
STAAR Surgical (STAA) and The Cooper Companies (COO) Head to Head AnalysisSTAAR Surgical (STAA) and The Cooper Companies (COO) Head to Head Analysis
www.americanbankingnews.com - April 15 at 1:21 AM
The Cooper Companies (COO) & STAAR Surgical (STAA) Head to Head SurveyThe Cooper Companies (COO) & STAAR Surgical (STAA) Head to Head Survey
www.americanbankingnews.com - April 15 at 1:21 AM
STAAR Surgical (STAA) Downgraded to "Sell" at Zacks Investment ResearchSTAAR Surgical (STAA) Downgraded to "Sell" at Zacks Investment Research
www.americanbankingnews.com - April 12 at 11:18 AM
STAAR Surgical (STAA) Rating Lowered to Sell at Zacks Investment ResearchSTAAR Surgical (STAA) Rating Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - April 6 at 10:45 AM
Contrasting National Vision (EYE) and STAAR Surgical (STAA)Contrasting National Vision (EYE) and STAAR Surgical (STAA)
www.americanbankingnews.com - April 4 at 9:34 PM
Zacks: STAAR Surgical (STAA) Receives Consensus Recommendation of "Buy" from BrokeragesZacks: STAAR Surgical (STAA) Receives Consensus Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - April 2 at 7:28 AM
STAAR Surgical (STAA) Downgraded to "Hold" at BidaskClubSTAAR Surgical (STAA) Downgraded to "Hold" at BidaskClub
www.americanbankingnews.com - March 29 at 9:15 AM
STAAR Surgical (STAA) Rating Increased to Buy at BidaskClubSTAAR Surgical (STAA) Rating Increased to Buy at BidaskClub
www.americanbankingnews.com - March 23 at 7:56 PM
Keith Holliday Sells 2,188 Shares of STAAR Surgical (STAA) StockKeith Holliday Sells 2,188 Shares of STAAR Surgical (STAA) Stock
www.americanbankingnews.com - March 22 at 2:40 PM
Insider Selling: STAAR Surgical (STAA) Insider Sells 2,833 Shares of StockInsider Selling: STAAR Surgical (STAA) Insider Sells 2,833 Shares of Stock
www.americanbankingnews.com - March 22 at 2:40 PM
Insider Selling: STAAR Surgical (STAA) Insider Sells 1,458 Shares of StockInsider Selling: STAAR Surgical (STAA) Insider Sells 1,458 Shares of Stock
www.americanbankingnews.com - March 21 at 7:50 PM
Insider Selling: STAAR Surgical (STAA) CEO Sells 6,667 Shares of StockInsider Selling: STAAR Surgical (STAA) CEO Sells 6,667 Shares of Stock
www.americanbankingnews.com - March 21 at 7:34 PM
Edited Transcript of STAA earnings conference call or presentation 28-Feb-18 9:30pm GMTEdited Transcript of STAA earnings conference call or presentation 28-Feb-18 9:30pm GMT
finance.yahoo.com - March 18 at 10:52 AM
BidaskClub Upgrades STAAR Surgical (STAA) to HoldBidaskClub Upgrades STAAR Surgical (STAA) to Hold
www.americanbankingnews.com - March 10 at 11:00 PM
STAAR Surgical (STAA) Position Trimmed by Millrace Asset Group Inc.STAAR Surgical (STAA) Position Trimmed by Millrace Asset Group Inc.
www.americanbankingnews.com - March 5 at 12:54 PM
BRIEF-Staar Surgical Q4 Sales $24.9 MillionBRIEF-Staar Surgical Q4 Sales $24.9 Million
www.reuters.com - March 2 at 3:35 PM
STAAR Surgical beats by $0.03, beats on revenueSTAAR Surgical beats by $0.03, beats on revenue
seekingalpha.com - March 2 at 3:35 PM
Form 8-K STAAR SURGICAL CO For: Feb 28Form 8-K STAAR SURGICAL CO For: Feb 28
www.streetinsider.com - March 2 at 3:35 PM
STAAR Surgical Reports Fourth Quarter and Full Year 2017 ResultsSTAAR Surgical Reports Fourth Quarter and Full Year 2017 Results
finance.yahoo.com - March 1 at 10:34 AM
STAAR Surgical (STAA) Issues Quarterly  Earnings ResultsSTAAR Surgical (STAA) Issues Quarterly Earnings Results
www.americanbankingnews.com - February 28 at 7:04 PM
Cortina Asset Management LLC Trims Holdings in STAAR Surgical (STAA)Cortina Asset Management LLC Trims Holdings in STAAR Surgical (STAA)
www.americanbankingnews.com - February 28 at 1:27 PM
Was STAAR Surgical Company’s (NASDAQ:STAA) Earnings Growth Better Than The Industry’s?Was STAAR Surgical Company’s (NASDAQ:STAA) Earnings Growth Better Than The Industry’s?
finance.yahoo.com - February 28 at 10:25 AM
74,178 Shares in STAAR Surgical (STAA) Acquired by Barrow Hanley Mewhinney & Strauss LLC74,178 Shares in STAAR Surgical (STAA) Acquired by Barrow Hanley Mewhinney & Strauss LLC
www.americanbankingnews.com - February 24 at 11:52 AM
STAAR Surgical (STAA) Scheduled to Post Quarterly Earnings on WednesdaySTAAR Surgical (STAA) Scheduled to Post Quarterly Earnings on Wednesday
www.americanbankingnews.com - February 21 at 2:40 AM
STAAR Surgical to Report Fourth Quarter Results...STAAR Surgical to Report Fourth Quarter Results...
www.benzinga.com - February 15 at 3:38 PM
STAAR Surgical to Report Fourth Quarter Results on February 28, 2018STAAR Surgical to Report Fourth Quarter Results on February 28, 2018
finance.yahoo.com - February 14 at 3:18 PM
STAAR Surgical (STAA) Expected to Post Earnings of $0.03 Per ShareSTAAR Surgical (STAA) Expected to Post Earnings of $0.03 Per Share
www.americanbankingnews.com - February 14 at 3:16 AM
The intraocular lens (IOL) market is projected to reach to USD 4.56 billion by 2022 from estimated USD 3.50 billion in 2017The intraocular lens (IOL) market is projected to reach to USD 4.56 billion by 2022 from estimated USD 3.50 billion in 2017
www.bizjournals.com - February 7 at 5:35 AM
Reviewing STAAR Surgical (STAA) & Steris (STE)Reviewing STAAR Surgical (STAA) & Steris (STE)
www.americanbankingnews.com - February 3 at 5:14 PM
Analysts Anticipate STAAR Surgical (STAA) to Announce $0.03 Earnings Per ShareAnalysts Anticipate STAAR Surgical (STAA) to Announce $0.03 Earnings Per Share
www.americanbankingnews.com - January 28 at 5:12 PM
Zacks: Analysts Expect STAAR Surgical (STAA) Will Post Earnings of $0.03 Per ShareZacks: Analysts Expect STAAR Surgical (STAA) Will Post Earnings of $0.03 Per Share
www.americanbankingnews.com - January 28 at 3:16 AM
STAAR Surgical (STAA) Raised to Sell at BidaskClubSTAAR Surgical (STAA) Raised to Sell at BidaskClub
www.americanbankingnews.com - January 17 at 12:14 AM
Zacks: Analysts Set $17.67 Target Price for STAAR Surgical (STAA)Zacks: Analysts Set $17.67 Target Price for STAAR Surgical (STAA)
www.americanbankingnews.com - January 12 at 11:06 PM
BRIEF-STAAR Surgical Sees ‍Double Digit Revenue Growth In FY 2018 Over 2017BRIEF-STAAR Surgical Sees ‍Double Digit Revenue Growth In FY 2018 Over 2017
www.reuters.com - January 8 at 3:34 PM
STAAR Surgical (STAA) Cut to Strong Sell at BidaskClubSTAAR Surgical (STAA) Cut to Strong Sell at BidaskClub
www.americanbankingnews.com - January 6 at 3:36 PM
ETFs with exposure to STAAR Surgical Co. : December 26, 2017ETFs with exposure to STAAR Surgical Co. : December 26, 2017
finance.yahoo.com - December 26 at 12:49 PM
STAAR Surgical Co. :STAA-US: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017STAAR Surgical Co. :STAA-US: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017
finance.yahoo.com - December 25 at 4:09 PM
Zacks: Brokerages Anticipate STAAR Surgical (STAA) Will Post Earnings of $0.03 Per ShareZacks: Brokerages Anticipate STAAR Surgical (STAA) Will Post Earnings of $0.03 Per Share
www.americanbankingnews.com - December 25 at 3:22 PM
Critical Comparison: Tandem Diabetes Care (TNDM) and STAAR Surgical (STAA)Critical Comparison: Tandem Diabetes Care (TNDM) and STAAR Surgical (STAA)
www.americanbankingnews.com - December 16 at 3:27 PM
STAAR Surgical Company (STAA) Expected to Announce Earnings of $0.03 Per ShareSTAAR Surgical Company (STAA) Expected to Announce Earnings of $0.03 Per Share
www.americanbankingnews.com - December 7 at 11:32 PM
Analysts Expect STAAR Surgical Company (STAA) to Announce $0.03 Earnings Per ShareAnalysts Expect STAAR Surgical Company (STAA) to Announce $0.03 Earnings Per Share
www.americanbankingnews.com - November 27 at 4:26 PM
STAAR Surgical Company (STAA) VP Sells $99,900.00 in StockSTAAR Surgical Company (STAA) VP Sells $99,900.00 in Stock
www.americanbankingnews.com - November 22 at 2:03 PM
Benchmark Co. Reiterates "Buy" Rating for STAAR Surgical Company (STAA)Benchmark Co. Reiterates "Buy" Rating for STAAR Surgical Company (STAA)
www.americanbankingnews.com - November 20 at 9:50 AM
Canaccord Genuity Boosts STAAR Surgical Company (STAA) Price Target to $20.00Canaccord Genuity Boosts STAAR Surgical Company (STAA) Price Target to $20.00
www.americanbankingnews.com - November 17 at 5:28 PM
STAAR Surgical Announces Webcast of Upcoming Investor and Analyst Day on November 16, 2017STAAR Surgical Announces Webcast of Upcoming Investor and Analyst Day on November 16, 2017
finance.yahoo.com - November 15 at 12:10 PM

SEC Filings

STAAR Surgical (NASDAQ:STAA) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

STAAR Surgical (NASDAQ:STAA) Income Statement, Balance Sheet and Cash Flow Statement

Chart

STAAR Surgical (NASDAQ STAA) Stock Chart for Sunday, April, 22, 2018

Loading chart…

This page was last updated on 4/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.